EN
Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience
Öz
Objective: The occurrence of drug reactions due to IgE or T-cell-mediated hypersensitivity reactions is referred to as drug allergy. Beta-lactam antibiotic (BLA) is the most common cause of drug allergy. In our study, we aimed to determine the true frequency of allergy in patients who presented to the children’s immunology and allergy polyclinic on suspicion of BLA allergy and performed drug provocation test (DPT) and to evaluate the clinical, demographic, and laboratory characteristics of these patients.
Methods: Between 2017 and 2023, 141 patients (75 immediate reaction and 66 non immediate reaction) aged 0-18 years who applied to our hospital’s pediatric immunology and allergy outpatient clinic with suspicion of BLA allergy and underwent DPT were included. Retrospective records from the last 6 years were examined from hospital data; age (month), sex, history of concomitant chronic diseases, history of additional allergic diseases, history of drug allergies in the family, type of reaction, serum total IgE, percentage of eosinophils (%), history of BLA use (penicillin V, penicillin G, ampicillin, amoxicillin etc.), specific IgE values, and drug intradermal test (IDT) results were recorded.
Results: In our study, 141 patients aged between 0 and 18 years were evaluated. 33 (23.4%) of them were IDT-positive. DPT was not performed because 24 patients did not have family permission and 9 patients experienced anaphylaxis. In our study, the BLA allergy rate determined by and/or skin tests was 26.9%, whereas the frequency of BLA allergy confirmed by DPT was 5.6%.
Conclusions: Beta lactam antibiotics are widely used worldwide and are the most common cause of drug-induced allergic reactions. Diagnosing a drug allergy thought to be associated with BLA based on history alone leads to the unnecessary use of broad-spectrum antibiotics and, consequently, to the development of antibiotic resistance. The patients should be referred to the child allergy department to be able to be definitively diagnosed for patients with suspected BLA drug allergy. Thus, we hope that unnecessary broad-spectrum antibiotics will be prescribed and that the use of expensive drugs will be prevented.
Anahtar Kelimeler
Kaynakça
- Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127(3):587-93. google scholar
- Arga M, Topal E. Anaphylaxis in children: what is it? What is it not? Clin Med Pediatr. 2020;12(2):103-13. google scholar
- Civelek E. Food allergy. Turk J Pediatr. 2020;14(3):199-199. google scholar
- Borch JE, Andersen KE, Bindslev-Jensen C. Prevalence of suspected and challenge-verified penicillin allergy in a university hospital population. Basic Clin Pharmacol Toxicol. 2006;98(4):357-62. google scholar
- Erkoçoğlu M, Mısırlıoğlu ED, Kocabaş CN. Diagnostic evaluation of drug allergy. Turk J Pediatr. 2015;9(1):66-70. google scholar
- Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12. google scholar
- Dykewicz MS, Lam JK. Drug hypersensitivity reactions. Med Clin North Am. 2020;104:109-28. google scholar
- Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139:683-93. google scholar
Ayrıntılar
Birincil Dil
İngilizce
Konular
Çocuk İmmünolojisi ve Alerji Hastalıkları
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
3 Ocak 2025
Gönderilme Tarihi
20 Ağustos 2024
Kabul Tarihi
6 Kasım 2024
Yayımlandığı Sayı
Yıl 2024 Cilt: 24 Sayı: 3
APA
Dilek, Ş., & Özçeker, D. (2025). Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience. Çocuk Dergisi, 24(3), 187-192. https://doi.org/10.26650/jchild.2024.1536100
AMA
1.Dilek Ş, Özçeker D. Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience. Çocuk Dergisi. 2025;24(3):187-192. doi:10.26650/jchild.2024.1536100
Chicago
Dilek, Şeyma, ve Deniz Özçeker. 2025. “Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience”. Çocuk Dergisi 24 (3): 187-92. https://doi.org/10.26650/jchild.2024.1536100.
EndNote
Dilek Ş, Özçeker D (01 Ocak 2025) Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience. Çocuk Dergisi 24 3 187–192.
IEEE
[1]Ş. Dilek ve D. Özçeker, “Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience”, Çocuk Dergisi, c. 24, sy 3, ss. 187–192, Oca. 2025, doi: 10.26650/jchild.2024.1536100.
ISNAD
Dilek, Şeyma - Özçeker, Deniz. “Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience”. Çocuk Dergisi 24/3 (01 Ocak 2025): 187-192. https://doi.org/10.26650/jchild.2024.1536100.
JAMA
1.Dilek Ş, Özçeker D. Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience. Çocuk Dergisi. 2025;24:187–192.
MLA
Dilek, Şeyma, ve Deniz Özçeker. “Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience”. Çocuk Dergisi, c. 24, sy 3, Ocak 2025, ss. 187-92, doi:10.26650/jchild.2024.1536100.
Vancouver
1.Şeyma Dilek, Deniz Özçeker. Retrospective Examınatıon of Children with Beta Lactam-Drug Allergy: A Single-Center Experience. Çocuk Dergisi. 01 Ocak 2025;24(3):187-92. doi:10.26650/jchild.2024.1536100